Authors: Mathur, P Wharton, RQ Jonas, SK Saini, S Allen-Mersh, TG

Citation: P. Mathur et al., Relationship between tumour vascularity and circulating cancer cells in patients with colorectal carcinoma, EUR J SUR O, 27(4), 2001, pp. 354-358

Authors: Khan, ZAH Jonas, SK Feldmann, KA Patel, H Wharton, RQ Tarragona, A Ivison, A Allen-Mersh, TG

Citation: Zah. Khan et al., p53 mutation and response to hepatic arterial floxuridine in patients withcolorectal liver metastases, J CANC RES, 127(11), 2001, pp. 675-680

Authors: Khan, ZAJ Jonas, SK Le-Marer, N Patel, H Wharton, RQ Tarragona, A Ivison, A Allen-Mersh, TG

Citation: Zaj. Khan et al., p53 mutations in primary and metastatic tumors and circulating tumor cellsfrom colorectal carcinoma patients, CLIN CANC R, 6(9), 2000, pp. 3499-3504

Authors: Wharton, RQ Patel, H Jonas, SK Glover, C Weston, M Allen-Mersh, TG

Citation: Rq. Wharton et al., Venesection needle coring increases positive results with RT-PCR for detection of circulating cells expressing CEA mRNA, CLIN EXP M, 18(4), 2000, pp. 291-294

Authors: Wharton, RQ Jones, SK Glover, C Khan, ZAJ Klokouzas, A Quinn, H Henry, M Allen-Mersh, TG

Citation: Rq. Wharton et al., Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples, CLIN CANC R, 5(12), 1999, pp. 4158-4163